Download PDF
Fortschr Neurol Psychiatr 2009; 77(5): 252-262
DOI: 10.1055/s-0028-1109324
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Pharmakologische Kombinationsbehandlung bipolarer Störungen

Psychopharmacological Combination Therapy in Bipolar DisorderA. Quante1 , F. van Hall1 , I. Anghelescu1
  • 1Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charité – Campus Benjamin Franklin, Berlin
Further Information

Publication History

Publication Date:
05 May 2009 (online)

    Permissions and Reprints

Zusammenfassung

Die Behandlung der bipolaren Störung hat in den letzten Jahren einen Wandel erfahren: Bei leichten Verläufen von manischen und depressiven Episoden sind immer noch monotherapeutische Ansätze zielführend, wobei zunehmend häufiger neben den „klassischen” Medikamenten wie Lithium, Valproinsäure und Carbamazepin auch atypische Antipsychotika (AAP) eingesetzt werden. Für die Therapie der manischen Episode sind derzeit die meisten verfügbaren AAP zugelassen, und auch für die Rückfallprophylaxe und die Behandlung der depressiven Episode existieren bereits Zulassungen. Bei mittelschweren und schweren depressiven oder manischen Episoden werden zunehmend Kombinationen eingesetzt, da sie in der Regel schneller wirken und teilweise auch besser verträglich sind. In einer Vielzahl von Studien konnte die Überlegenheit der Kombinationsbehandlung im Gegensatz zu verschiedenen, etablierten Monotherapien gezeigt werden. Dieser Übersichtsartikel fasst die vorhandenen Studien und Ergebnisse mit Fokus auf die Kombinationsbehandlung zusammen, um aktuelle medikamentöse Therapieempfehlungen für eine effektive Behandlung der bipolaren Störung zu geben.

Abstract

In the course of time, the treatment regime of bipolar disorder has changed: in mild cases of manic and depressive episodes, monotherapeutic approaches are still commonly used. Besides the use of the common agents like lithium, valproatic acid and carbamazepine, other agents such as atypical antipsychotics (AAP) are used more frequently. For the therapy of manic episodes, most of the usual AAP are approved; some of them are or will be approved in the near future even for the continuation therapy and for depressive episodes. For moderate and severe courses of depressive or manic episodes, combination therapy strategies are used more often. Combination strategies seem to be more effective than monotherapeutic treatments, because of faster effects and better tolerance. In a lot of studies, these positive effects and advantages in contrast to monotherapeutic treatments could be proven. In this review article, studies and results with the focus on combination therapy will be summarised to recommend the ”state-of-the-art”-treatment for bipolar disorder.

Schlüsselwörter

bipolare Störung - Kombinationsbehandlung - Pharmakotherapie - Antipsychotika - Stimmungsstabilisierer

Key words

bipolar disorder - combination therapy - pharmacotherapy - antipsychotics - mood stabilizer

Literatur

  • 1 Severus W E, Watzke S, Brieger P. Bipolar affective disorders. Part II: Genetics, cognitions and therapy.  Fortschr Neurol Psychiatr. 2008;  76 294-304
    Google Scholar
  • 2 Brieger P. Bipolar affective disorders. Part I: diagnosis, epidemiology and course.  Fortschr Neurol Psychiatr. 2007;  75 673-682
    Google Scholar
  • 3 Fountoulakis K N, Vieta E, Siamouli M. et al . Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.  Ann Gen Psychiatry. 2007;  6 27
    Google Scholar
  • 4 Yatham L N, Kennedy S H, O’Donovan C. et al . Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.  Bipolar Disord. 2005;  7 (Suppl 3) 5-69
    Google Scholar
  • 5 O’Dowd A. NICE issues new guidance to improve the treatment of bipolar disorder.  BMJ. 2006;  333 220
    Google Scholar
  • 6 American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision).  Am J Psychiatry. 2002;  159 1-50
    Google Scholar
  • 7 Muller-Oerlinghausen B, Ahrens B, Grof E. et al . The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness.  Acta Psychiatr Scand. 1992;  86 218-222
    Google Scholar
  • 8 Schou M. Relapse prevention in manic depressive illness: important and unimportant factors.  Can J Psychiatry. 1991;  36 502-506
    Google Scholar
  • 9 Roy-Byrne P P, Post R M, Hambrick D D. et al . Suicide and course of illness in major affective disorder.  J Affect Disord. 1988;  15 1-8
    Google Scholar
  • 10 Sussman N, Mullen J, Paulsson B. et al . Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.  J Affect Disord. 2007;  100 (Suppl 1) S55-S63
    Google Scholar
  • 11 Zarate C A, Quiroz J A. Combination treatment in bipolar disorder: a review of controlled trials.  Bipolar Disord. 2003;  5 217-225
    Google Scholar
  • 12 Miller D S, Yatham L N, Lam R W. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.  J Clin Psychiatry. 2001;  62 975-980
    Google Scholar
  • 13 Perlis R H. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.  Am J Manag Care. 2007;  13 S178-S188
    Google Scholar
  • 14 Perlis R H, Welge J A, Vornik L A. et al . Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.  J Clin Psychiatry. 2006;  67 509-516
    Google Scholar
  • 15 Leverich G S, Altshuler L L, Frye M A. et al . Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.  Am J Psychiatry. 2006;  163 232-239
    Google Scholar
  • 16 Young L T, Joffe R T, Robb J C. et al . Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.  Am J Psychiatry. 2000;  157 124-126
    Google Scholar
  • 17 Prien R F, Kupfer D J, Mansky P A. et al . Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.  Arch Gen Psychiatry. 1984;  41 1096-1104
    Google Scholar
  • 18 Prien R F. NIMH report. Five-center study clarifies use of lithium, imipramine for recurrent affective disorders.  Hosp Community Psychiatry. 1984;  35 1097-1098
    Google Scholar
  • 19 Sachs G S, Nierenberg A A, Calabrese J R. et al . Effectiveness of adjunctive antidepressant treatment for bipolar depression.  N Engl J Med. 2007;  356 1711-1722
    Google Scholar
  • 20 Merkl Jr A, Regen F, Schindler F. et al . Mixed episodes in bipolar disorder: a review.  Fortschr Neurol Psychiatr. 2007;  75 323-330
    Google Scholar
  • 21 Grunze H, Kasper S, Goodwin G. et al . World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.  World J Biol Psychiatry. 2002;  3 115-124
    Google Scholar
  • 22 Post R M, Leverich G S, Altshuler L. et al . Lithium-discontinuation-induced refractoriness: preliminary observations.  Am J Psychiatry. 1992;  149 1727-1729
    Google Scholar
  • 23 Smith L A, Cornelius V, Warnock A. et al . Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.  Bipolar Disord. 2007;  9 394-412
    Google Scholar
  • 24 Calabrese J R, Rapport D J. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder.  J Clin Psychiatry. 1999;  60 (Suppl 5) 5-13
    Google Scholar
  • 25 Bowden C L, Calabrese J R, McElroy S L. et al . A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.  Arch Gen Psychiatry. 2000;  57 481-489
    Google Scholar
  • 26 Freeman T W, Clothier J L, Pazzaglia P. et al . A double-blind comparison of valproate and lithium in the treatment of acute mania.  Am J Psychiatry. 1992;  149 108-111
    Google Scholar
  • 27 Calabrese J R, Rapport D J, Kimmel S E. et al . Rapid cycling bipolar disorder and its treatment with valproate.  Can J Psychiatry. 1993;  38 S57-S61
    Google Scholar
  • 28 Davis L L, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study.  J Affect Disord. 2005;  85 259-266
    Google Scholar
  • 29 Gyulai L, Bowden C L, McElroy S L. et al . Maintenance efficacy of divalproex in the prevention of bipolar depression.  Neuropsychopharmacology. 2003;  28 1374-1382
    Google Scholar
  • 30 Owen R T. Extended-release carbamazepine for acute bipolar mania: a review.  Drugs Today. 2006;  42 283-289
    Google Scholar
  • 31 Hartong E G, Moleman P, Hoogduin C A. et al . Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.  J Clin Psychiatry. 2003;  64 144-151
    Google Scholar
  • 32 Bowden C L, Calabrese J R, Sachs G. et al . A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.  Arch Gen Psychiatry. 2003;  60 392-400
    Google Scholar
  • 33 Brown E B, McElroy S L, Keck P E. et al . A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.  J Clin Psychiatry. 2006;  67 1025-1033
    Google Scholar
  • 34 Calabrese J R, Goldberg J F, Ketter T A. et al . Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.  Biol Psychiatry. 2006;  59 1061-1064
    Google Scholar
  • 35 Calabrese J R, Bowden C L, Sachs G S. et al . A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.  J Clin Psychiatry. 1999;  60 79-88
    Google Scholar
  • 36 Kushner S F, Khan Jr A, Lane R. et al . Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.  Bipolar Disord. 2006;  8 15-27
    Google Scholar
  • 37 Vieta E, Manuel G J, Martinez-Aran A. et al . A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.  J Clin Psychiatry. 2006;  67 473-477
    Google Scholar
  • 38 Smith L A, Cornelius V, Warnock A. et al . Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.  Bipolar Disord. 2007;  9 551-560
    Google Scholar
  • 39 Rendell J M, Gijsman H J, Bauer M S. et al . Risperidone alone or in combination for acute mania.  Cochrane Database Syst Rev. 2006;  CD004043
    Google Scholar
  • 40 Gopal S, Steffens D C, Kramer M L. et al . Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.  J Clin Psychiatry. 2005;  66 1016-1020
    Google Scholar
  • 41 Tohen M, Jacobs T G, Grundy S L. et al . Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group.  Arch Gen Psychiatry. 2000;  57 841-849
    Google Scholar
  • 42 Tohen M, Greil W, Calabrese J R. et al . Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.  Am J Psychiatry. 2005;  162 1281-1290
    Google Scholar
  • 43 Bowden C L, Grunze H, Mullen J. et al . A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.  J Clin Psychiatry. 2005;  66 111-121
    Google Scholar
  • 44 Cookson J, Keck P E, Ketter T A. et al . Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.  Int Clin Psychopharmacol. 2007;  22 93-100
    Google Scholar
  • 45 Weisler R H, Calabrese J R, Thase M E. et al . Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies.  J Clin Psychiatry. 2008;  69 769-782
    Google Scholar
  • 46 Altamura A C, Salvadori Jr D, Madaro D. et al . Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study.  J Affect Disord. 2003;  76 267-271
    Google Scholar
  • 47 Keck P E, Marcus Jr R, Tourkodimitris S. et al . A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.  Am J Psychiatry. 2003;  160 1651-1658
    Google Scholar
  • 48 Keck P E, Calabrese J R, McQuade R D. et al . A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.  J Clin Psychiatry. 2006;  67 626-637
    Google Scholar
  • 49 Keck Jr P E, Calabrese J R, McIntyre R S. et al . Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.  J Clin Psychiatry. 2007;  68 1480-1491
    Google Scholar
  • 50 Thase M E, Jonas Jr A, Khan A. et al . Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.  J Clin Psychopharmacol. 2008;  28 13-20
    Google Scholar
  • 51 Keck P E, Versiani Jr M, Potkin S. et al . Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.  Am J Psychiatry. 2003;  160 741-748
    Google Scholar
  • 52 Potkin S G, Keck P E, Segal Jr S. et al . Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.  J Clin Psychopharmacol. 2005;  25 301-310
    Google Scholar
  • 53 Versiani M. Ziprasidone in bipolar disorder.  Expert Opin Pharmacother. 2006;  7 1221-1228
    Google Scholar
  • 54 Pande A C, Crockatt J G, Janney C A. et al . Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.  Bipolar Disord. 2000;  2 249-255
    Google Scholar
  • 55 Muller-Oerlinghausen B, Retzow A, Henn F A. et al . Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.  J Clin Psychopharmacol. 2000;  20 195-203
    Google Scholar
  • 56 Tohen M, Chengappa K N, Suppes T. et al . Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.  Arch Gen Psychiatry. 2002;  59 62-69
    Google Scholar
  • 57 Sachs G S, Grossman F, Ghaemi S N. et al . Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.  Am J Psychiatry. 2002;  159 1146-1154
    Google Scholar
  • 58 Yatham L N, Grossman F, Augustyns I. et al . Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.  Br J Psychiatry. 2003;  182 141-147
    Google Scholar
  • 59 Vieta E, Herraiz M, Parramon G. et al . Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain.  J Affect Disord. 2002;  72 15-19
    Google Scholar
  • 60 Vieta E, T’joen C, McQuade R D. et al . Efficacy of Adjunctive Aripiprazole to Either Valproate or Lithium in Bipolar Mania Patients Partially Nonresponsive to Valproate/Lithium Monotherapy: A Placebo-Controlled Study.  Am J Psychiatry. 2008;  165 1316-1325
    Google Scholar
  • 61 Sajatovic M, Brescan D W, Perez D E. et al . Quetiapine alone and added to a mood stabilizer for serious mood disorders.  J Clin Psychiatry. 2001;  62 728-732
    Google Scholar
  • 62 Delbello M P, Kowatch R A, Adler C M. et al . A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.  J Am Acad Child Adolesc Psychiatry. 2006;  45 305-313
    Google Scholar
  • 63 Sachs G, Chengappa K N, Suppes T. et al . Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.  Bipolar Disord. 2004;  6 213-223
    Google Scholar
  • 64 Yatham L N, Paulsson B, Mullen J. et al . Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.  J Clin Psychopharmacol. 2004;  24 599-606
    Google Scholar
  • 65 Yatham L N, Vieta E, Young A H. et al . A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.  Int Clin Psychopharmacol. 2007;  22 212-220
    Google Scholar
  • 66 Vieta E, Panicali F, Goetz I. et al . Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.  J Affect Disord. 2008;  106 63-72
    Google Scholar
  • 67 Wehr T A, Goodwin F K. Rapid cycling in manic-depressives induced by tricyclic antidepressants.  Arch Gen Psychiatry. 1979;  36 555-559
    Google Scholar
  • 68 Quitkin F M, Kane J, Rifkin A. et al . Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study.  Arch Gen Psychiatry. 1981;  38 902-907
    Google Scholar
  • 69 Denicoff K D, Smith-Jackson E E, Disney E R. et al . Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.  J Clin Psychiatry. 1997;  58 470-478
    Google Scholar
  • 70 Solomon D A, Ryan C E, Keitner G I. et al . A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder.  J Clin Psychiatry. 1997;  58 95-99
    Google Scholar
  • 71 Denicoff K D, Smith-Jackson E E, Bryan A L. et al . Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.  Am J Psychiatry. 1997;  154 1456-1458
    Google Scholar
  • 72 Tohen M, Chengappa K N, Suppes T. et al . Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.  Br J Psychiatry. 2004;  184 337-345
    Google Scholar
  • 73 Vieta E, Goikolea J M, Corbella B. et al . Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.  J Clin Psychiatry. 2001;  62 818-825
    Google Scholar
  • 74 Yatham L N, Binder C, Riccardelli R. et al . Risperidone in acute and continuation treatment of mania.  Int Clin Psychopharmacol. 2003;  18 227-235
    Google Scholar
  • 75 Vieta E, Suppes T, Eggens I. et al . Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).  J Affect Disord. 2008;  109 251-263
    Google Scholar
  • 76 Altamura A C, Mundo E, Dell’Osso B. et al . Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study.  J Affect Disord. 2008;  110 135-141
    Google Scholar
  • 77 Sachs G S, Lafer B, Stoll A L. et al . A double-blind trial of bupropion versus desipramine for bipolar depression.  J Clin Psychiatry. 1994;  55 391-393
    Google Scholar
  • 78 Nemeroff C B, Evans D L, Gyulai L. et al . Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.  Am J Psychiatry. 2001;  158 906-912
    Google Scholar
  • 79 Young L T, Joffe R T, Robb J C. et al . Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.  Am J Psychiatry. 2000;  157 124-126
    Google Scholar
  • 80 Vieta E, Martinez-Aran A, Goikolea J M. et al . A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.  J Clin Psychiatry. 2002;  63 508-512
    Google Scholar
  • 81 Tohen M, Vieta E, Calabrese J. et al . Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.  Arch Gen Psychiatry. 2003;  60 1079-1088
    Google Scholar

Dr. med. Arnim Quante

Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charité – Campus Benjamin Franklin

Eschenallee 3

14050 Berlin

Email: arnim.quante@charite.de

      >